Recruiting for a phase II Clinical Study of CD19-targeted Chimeric Antigen Receptor (CAR) T Cells Injection, for Relapsed and Refractory (R/R) Large B-cell Lymphoma. Those interested can contact us at given below number. #lymphoma#clinicaltrials#cartcelltherapy#cancerfax
Join us on 21 September for a free webinar from the #cochranelearninglive series - Searching clinical trials registers: guide for systematic reviewers. Sign up open to everyone bit.ly/3kPt6Cd